ENDRA LIFE SCIENCES INC. Development in Process
ENDRA LIFE SCIENCES INC. (NDRA) had Development in Process of $125.15 thousand as of 2024-09-30, per its 10-Q/A filed 2024-11-21.
Financial Statements › Balance Sheet › Assets
us-gaap:DevelopmentInProcess · last filed 2024-11-21
- 2024-09-30: Development in Process $125.15K.
- 2024-06-30: Development in Process $125.15K.
- 2024-03-31: Development in Process $125.15K.
- 2023-12-31: Development in Process $125.15K.
| Period end | Development in Process |
|---|---|
| 2024-09-30 | $125.15K 10-Q/A · filed 2024-11-21 |
| 2024-06-30 | $125.15K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $125.15K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $125.15K 10-Q/A · filed 2024-11-21 |
| 2023-09-30 | $140.62K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $140.62K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $140.62K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $140.62K 10-K · filed 2024-03-28 |
| 2022-09-30 | $143.48K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $143.48K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $107.68K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $107.68K 10-K · filed 2023-03-16 |
| 2020-12-31 | $79.21K 10-K · filed 2022-03-30 |
| 2019-12-31 | $43.60K 10-K · filed 2021-03-25 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |